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A B S T R A C T
Chronic ingestion of caffeine causes dependence and sleep disturbance in children and adolescents. In
rodents, the administration of caffeine may produce behavioral cross-sensitization to some
psychostimulants, such as dopaminergic psychoactive drugs. Methylphenidate (MPH; Ritalin1) is a
psychostimulant used in pediatric- and adult human populations to manage the symptoms associated
with attention-deﬁcit hyperactivity disorder (ADHD). Previous studies have suggested that dopamine-
and cAMP-regulated phosphoproteins of 32 kDa (DARPP-32) participate in the manifestation of
behavioral activity following ingestion of caffeine or MPH. The aim of the present study was to evaluate
whether long-term administration of low doses of caffeine in rodents during their adolescence induces
cross-sensitization to MPH challenge in their adulthood and investigate the involvement of DARPP-32 in
this model. Young rats (P25) consumed water or caffeine (0.3 g/L; mean consumption was 7.5 mg/day/
kg) for 28 days. The caffeine consumption was then suspended for 14 days (washout period) when the
animals received saline solution or MPH (1, 2, or 10 mg/kg) (P67) intraperitoneally. The locomotor
activity of these rats was assessed using the open-ﬁeld test, following which the immunocontent of
DARPP-32 was evaluated in samples of their prefrontal cortex, striatum, or hippocampus. Rats
chronically exposed to caffeine in their adolescent period and to inactive doses of MPH (1 mg/kg) in
adulthood showed augmented locomotor activity. The behavioral effect observed was accompanied by
increased levels of DARPP-32 in the striatum and prefrontal cortex compared to control groups (saline or
caffeine). However, no alteration caused by these treatments was noted in the hippocampus. In
conclusion, chronic caffeine exposure induces likely long-term cross-sensitization to MPH in a DARPP-
32-dependent pathway.
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Caffeine is a psychoactive substance present in several
beverages and foods widely consumed in large amounts by
children and adolescents with potential behavioral effects, like
disruption of sleep and improved performance in tasks requiring
close attention (Pollak and Bright, 2003; Bernstein et al., 2002).
Caffeine is a nonselective competitive adenosine A1 and A2A
receptor antagonist with similar afﬁnity (Fisone et al., 2004). Its
action on adenosine receptors seems necessary to enhance motor
activity in experimental animals (Karcz-Kubicha et al., 2003);
however, this effect has been described as the consequence of its* Corresponding author. Tel.: +55 48 3431 2759; fax: +55 48 3431 2671.
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Open access under the Elsevier OA license.blocks on adenosine A2A receptors, rather than on A1 receptors (El
Yacoubi et al., 2000).
Adenosine A1 and A2 receptors are widely dispersed in the brain
at different intensities, which in turn contribute to the regulation
of other neurotransmitters. Behavioral- and neurochemical
evidences point to an antagonistic interaction relationship
between adenosine A2A–dopamine D2 receptors (Ferre et al.,
2004) and probably adenosine A1–dopamine D1 receptors (Franco
et al., 2007). Adenosine A2A and dopamine D1 receptors couple to
members of the G-proteins family that are positively related to
intracellular cAMP production, as consequence of the activation of
signaling via the PKA pathway (Stoof and Kebabian, 1981;
Fredholm, 1977) and results in increased phosphorylation of
dopamine- and cAMP-regulated phosphoproteins of 32 kDa
(DARPP-32) (Walaas et al., 1983). DARPP-32 is an important
modulator of the cAMP/PKA pathway, highly expressed in
Fig. 1. Effect on locomotion of long-term exposure to caffeine in adolescent rats
MPH challenged in adulthood. Cumulative values of crossings (A) and rearings (B) in
animals exposed to bottles of water (open symbols) or to bottles of caffeine 0.3 g/L
(ﬁlled symbols), and challenged with acute MPH (1, 2, or 10 mg/kg) injections in
adulthood measured as described in Section 2. Panels show data expressed as
media  S.E.M. of 11–15 animals. aP < 0.05 compared to control water group, two-way
ANOVA and post hoc Tukey HSD.
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in motor activity, and in striatopallidal neurons, the cascade is
associated with motor depression (Borgkvist and Fisone, 2007).
Therefore, DARPP-32 is a potential molecular target for integrating
the effects of adenosine- and dopamine receptors in locomotion
(Lin et al., 2002). The stimulant action of caffeine administered
chronically (Lindskog et al., 2002) and cocaine administered either
acutely (Svenningsson et al., 2000) or chronically (Bibb et al., 2001)
is related to a persistent increase in DARPP-32 phosphorylation.
In rodents, chronic caffeine induces behavioral cross-sensitiza-
tion todopaminergic- (Horger et al., 1991; Bastia et al., 2005; Simola
et al., 2006a) and glutamatergic systems (Dall’Igna et al., 2003; da
Silva et al., 2005). The cross-sensitization phenomenon is described
as a progressive behavioral augmentation that occurswhen the pre-
treatment with one stimulant leads to greater sensitivity to another
(Aizenstein et al., 1990). Studies have demonstrated that adolescent
rats pretreated with methylphenidate (MPH) develop subsequent
cross-sensitization to amphetamine (Valvassori et al., 2007) or to
cocaine in adulthood (Torres-Reveron and Dow-Edwards, 2005). A
signiﬁcantproportionof the sensitizationoccursvia activationof the
striatal D1 receptors (Svenningsson et al., 2000), mediating the
rewarding properties of the drugs of abuse. In addition, an
adaptative change in the neuronal circuits leads to abnormal
DARPP-32 regulation participating in the induction- and expression
of behavioral sensitization (Scheggi et al., 2007). In spite of these
observations, little is known about long-lasting effect of caffeine-
induced cross-sensitization toMPH in adulthoodwhen a lower dose
of caffeine is ingested during adolescence. In this study,we evaluate
whether long-term caffeine administration in adolescent rats
induces cross-sensitization after MPH challenge in adulthood with
the involvement of DARPP-32. Our results demonstrated that rats
administered caffeine during adolescence express behavioral cross-
sensitization to MPH in adulthood, with changes in DARPP-32
content mainly in the striatum.
2. Experimental procedures
2.1. Animals
Male Wistar rats weighing 75–85 g (age 25 days) were used to begin the
experiment. The animals were housed ﬁve to a cage (30 cm  40 cm  15 cm) with
free access to food and water (or caffeine, where mentioned), and maintained on a
12-h light/dark cycle (lights on at 07:00 h). All experimental procedures performed
were in accordance with the recommendations of the National Institute of Health
Guide for the Care and Use of Laboratory Animals and the Brazilian Society for
Neuroscience and Behavior (SBNeC) for animal care. The local ethics committee
(Universidade do Extremo Sul Catarinense) approved the study (prot. 532/2007).
2.2. Pharmacological procedures
In the chronic treatment, caffeine anhydrate base solution (0.3 mg/L) (da Silva
et al., 2003) was administered by allowing animals (age 25 days) free access to the
solution in tap water bottles for 28 days (up to age 53 days, adolescence period) as
their only drinking ﬂuid. Control animals received ordinary tap water. Caffeine
solutions were exchanged every third day for a fresh batch and the daily intake was
measured in all groups. After chronic treatment, rats were randomly submitted to a
14-day washout period when every animal received ordinary water. On the 15th
day (age 67 days, adulthood) they received acute challenge and were divided into
eight groups as follows: (i) CRL group: administered chronic water and acute
administration with saline solution (NaCl 0.9%, w/v); (ii) MPH1, (iii) MPH2 or (iv)
MPH10 groups: administered chronic water and acute treatment with MPH 1, 2, or
10 mg/kg injected intraperitoneally, respectively; (v) CRL CAF group: administered
chronic caffeine and acute administration with saline solution; (vi) CAF MPH1, (vii)
CAF MPH2; or (viii) CAF MPH 10 groups: administered chronic caffeine and acute
treatment with MPH (Ritalin1) 1, 2, or 10 mg/kg, respectively. Twelve up to 15
animals were used per group, in a total of 101 animal for the experimental design.
The dosages of MPH were selected according to a previous study that had shown
sensitization of rats in adulthood to challenge with AMPH after chronic treatment
with MPH in their teenage (Valvassori et al., 2007).
2.3. Locomotor activity
The locomotor activity of the rats was assessed 2 h after acute injection of saline
or MPH using the open-ﬁeld apparatus (Vianna et al., 2001). At least 16 animals perdaywere submitted to tasks from 9 a.m. to 12 a.m. and aminimum of one animal of
each group was evaluated. This study was conducted in an open ﬁeld
40 cm  60 cm surrounded by 50-cm-high walls. The ﬂoor of the apparatus was
of varnished wood and divided into nine equal rectangles by black lines. The
animals were gently placed on the left rear rectangle and were allowed to explore
the area. Crossings of the black lines and rearings by the rats were counted for a
period of 5 min by expert blind observers.
2.4. Preparation of tissue sample
Immediately after behavioral assessment, the animals were decapitated and the
cerebral prefrontal cortex, hippocampus, and striatum were dissected and rapidly
solubilized with SDS-stopping solution (4% SDS, 2 mM EDTA, 8% b-mercaptoetha-
nol, and 50 mM Tris, pH 6.8). Aliquots of the proteins were quantiﬁed (Bradford,
1976) and extracts stored at 80 8C until the preparation of samples for
immunoblot analysis.
2.5. Immunoblot analysis
Equal amounts of protein (50mg) were loaded into bis–Tris NuPAGE 4–12% gels
(Invitrogen) and submitted to electrophoresis as recommended by the manufac-
turer, followed by their transfer to nitrocellulose membranes (Hybond ECL,
Amersham Pharmacia Biotech). Protein loading and efﬁciency of blot transfer were
monitored by staining with Ponceau S (0.5% ponceau/1% acetic acid) (Sigma
Chemical Co., USA) (Towbin et al., 1979). The membranes were blocked for 45 min
with TBS-T (tris-buffered saline and Tween 20 0.1%, pH 7.4) plus non-fat milk 5%.
Membrane blots were incubated with polyclonal anti-DARPP-32 (1:500 – H-62,
Santa Cruz Biotechnology) and monoclonal anti-actin antibody (1:7000 –
MAB1501R – Chemicon) diluted in TBS-T and stored overnight at 4 8C. After
washing, the membranes were incubated for duration of one hour with goat anti-
rabbit IgG (1:15,000) or goat anti-mouse IgG (1:7000) horseradish peroxidase
(HRP)-conjugated secondary antibodies, respectively, which were purchased from
Molecular Probes). Immunocomplexes were visualized using the enhancing
chemiluminescence detection system (ECL Plus, Amersham Biosciences) as
Fig. 2. Effect of long-termexposurewithcaffeine inadolescent ratsMPHchallenged in
adulthood onDARP-32 contents. DARPP-32 immundetections in (A) prefrontal cortex
(PfCx), (B) striatum (Str), and (C) hippocampus (Hip)were determinedasdescribed in
Section 2. Upper panels show representative DARPP-32 and actin immunoblots;
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analysis was performed using Scion Image Software version Beta 4.0.2 (Scion
Corporation, Scion Corporation, Frederick, MD).
2.6. Statistical analysis
Results were analyzed by STATISTICA version 7.0 software (StatSoft, Inc., USA).
All data are presented as mean values  S.E.M. (standard error of the mean), and each
value reﬂects the mean of 11–15 animals per group for behavioral parameters or the
mean of 4–5 animals per group for immunoblot analysis. In all cases, statistical
analyses were performed employing two-way analysis of variance (ANOVA) with
chronic- and acute treatments as the main factors, followed by the Tukey HSD test for
behavioral analysis and the Duncan test for immunoblot analysis. The level of
signiﬁcant difference was accepted at P < 0.05.
3. Results
Caffeine consumption of the rats was estimated from the loss of
water from the drinking bottles. The daily liquid intake of all
groups of rats (control and caffeine-treated with 0.3 g/L) did not
differ from one another (data not shown) and the mean caffeine
dose was 7.5 mg/kg per day.
In the open-ﬁeld tasks (Fig. 1), we observed an increase on the
horizontal- [F(3,91) = 1.108, P < 0.05] (Fig. 1A; crossing) and the
vertical locomotor behavior [F(3,91) = 2.048, P < 0.01] (Fig. 1B;
rearing) in rats acutely treatedwithMPH 2 mg/kg challenge (MPH2
group), independent of their pre-treatment. Nevertheless, MPH
1 mg/kg challenge did not induce any modiﬁcation per se, but did
induce a hyperlocomotion in those rats pre-treated with caffeine
during adolescence (CAF MPH1 group) [crossing: F(3,91) = 1.108,
P < 0.01; rearing: F(3,91) = 2.048, P < 0.001]. Interestingly, neither
chronic pre-exposure of caffeine (CRL CAF group) nor acute low
dose ofMPH alone (MPH1 group) altered the locomotor behavior of
the animals.
The measurement of content of DARPP-32 protein normalized
by actin content showed its different modulations to caffeine and/
or MPH in the cerebral area analyzed (Fig. 2). Early treatment with
MPH acute challenge [F(3,24) = 5.747, P < 0.001] as low dose of
caffeine [F(3,24) = 5.747, P < 0.0001] reduced the DARPP-32 expres-
sion in the prefrontal cortex (Fig. 2A). The pre-treatment with
caffeine in adolescence potentiated the effect induced by MPH
2 mg/kg (CAF MPH 2 group) [F(3,24) = 5.747, P < 0.05]. Conversely,
treatment with all doses of MPH acute challenges or chronic
treatment with caffeine induced increases in the contents of
DARPP-32 in the striatum [F(3,24) = 7.466, P < 0.0001] (Fig. 2B). In
this cerebral area, pre-treatment with caffeine potentiated the
increase in the content of protein induced by MPH 1 mg/Kg [CAF
MPH1 group: F(3,24) = 7.466, P < 0.01]. Interestingly, in areas of the
prefrontal cortex and striatum, caffeine-induced changes in the
content of DARPP-32 showed an important long-lasting effect,
which was altered by all doses of MPH only in the striatum of rats
[CAF MPH1 group: F(3,24) = 7.466, vs. CAF group = P < 0.001, vs.
MPH1 group = P < 0.01; CAF MPH2 group and CAF MPH10 group:
F(3,24) = 7.466, vs. CAF group = P < 0.01]. The evaluation of DARPP-
32 content in the hippocampus did not show any signiﬁcant
changes following all treatments (Fig. 2C).
4. Discussion
The present ﬁndings show for the ﬁrst time the long-lasting
effects of the interaction of caffeine and MPH at adulthood,
following the chronic free exposure of adolescent rats to low doses
of caffeine. The sensitization of dopaminergic drugs, such as MPH,lowerpanel shows summaryofopticaldensitydataexpressedasmediaof normalized
DARPP-32/actin contents S.E.M. of 4–5 independent samples from rats. aP < 0.05 vs.
control water group; bP < 0.05 vs. caffeine control group; cP < 0.05 vs. respective MPH
group challenge [MPH 2 in (A); MPH 1 in (B)]; two-way ANOVA and post hoc Duncan.
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protocols of treatments were carried out at the same phase or age
of animals (Schenk et al., 1990; Jain and Holtzman, 2005; Simola
et al., 2006b). The present model was designed to investigate
whether chronic exposure to caffeine in the adolescent period
induces behavioral cross-sensitization to MPH in adulthood after
the washout period, and besides investigated the possible
involvement of the DARPP-32 protein in this phenomenon.
Caffeine exerts ontogenetic psychostimulant effects in humans
(Oliveto et al., 1992; Bernstein et al., 2002; Pollak and Bright, 2003),
and in rats its effects have been demonstrated to be inﬂuenced by
dopamine transmission. Because caffeine induces the release of
dopamine in the striatal compartments (Solinas et al., 2002) and
prefrontal cortex (Acquas et al., 2002), its effect on motor
activation is reduced by dopaminergic receptor antagonists
(Garrett and Holtzman, 1994), whereas sensitization of dopamine
receptors enhances the caffeine effect (Fenu and Morelli, 1998).
Several lines of evidence have established that the psychostimu-
lant effects of caffeine are mediated by an antagonism at the
adenosine A1 and A2 receptors levels (Fisone et al., 2004), whereas
the adenosine A2A receptors play a fundamental role in caffeine-
mediated motor behavior (El Yacoubi et al., 2000). The dopamine-
and adenosine cross-talk via caffeine have been supported by
identiﬁcation of heteromeric dimerization of the adenosine A2A
and dopamine D2 receptors (Ferre et al., 2004; Tsai, 2005), and
probably adenosine A1 receptors regulate the D1 receptors
(Yabuuchi et al., 2006). The striatal complex is involved in the
behavioral responses to motivational stimuli due its dorsolateral
area innervation from the substantia nigra pars compact (SNpc)
involved in motor functions, and its ventral- (nucleus accumbens)
and dorso medial areas innervation from the ventral tegmental
area involved in motivational- and reward behaviors. Dopamine
via D1 receptors controls mainly the motor function via increase of
the cAMP signaling pathwaywhereas via D2 receptors are involved
in motivation via a reduction of its pathway (Borgkvist and Fisone,
2007). Adenosine A1 and A2A also are expressed in the striatal area;
however, the A1 is present in lower density (Rivkees et al., 1995)
and the A2A is highly expressed postsynaptically (Fink et al., 1992).
The observed potentiation of locomotion of rats induced by
exposure to caffeine during adolescence and MPH challenge at
adulthood at low dose could represent the interaction referred
above. In addition, probably this behavioral sensitization had the
participation of DARPP-32 in the striatum, since studies have
demonstrated its activation in this phenomenon (Scheggi et al.,
2007) that present data corroborated when the caffeine treatment
during adolescence and acute administration of MPH challenge in
adulthood signiﬁcantly changed the content of protein. DARPP-32
protein was initially found to be a major target for dopamine-
activated adenylyl cyclase and protein kinase A (PKA) in the
striatum (Walaas et al., 1983). A prominent aspect of the
distribution of DARPP-32 in the brain is its high enrichment in
dopaminergic neurons, including the striatal medium spiny
projection neurons (Anderson and Reiner, 1991) and in lower
density in the brain regions receiving dopaminergic projections,
including the prefrontal cortex (Ouimet et al., 1984). The
involvement of DARPP-32 in the action of caffeine (Lindskog
et al., 2002) and amphetamines demonstrates the importance of
the cAMP/PKA pathway in the induction of behavioral stimulation
(Svenningsson et al., 2000). Since dopamine exerts a strong
inﬂuence on inhibition in the prefrontal cortex and the low levels
of dopamine in this area preferentially act on D1 receptors
(Trantham-Davidson et al., 2004), probably the reduced content of
DARPP-32 observed here represents the effect of long-term
treatment with caffeine in teenage rather than an effect induced
by the dopamine released. The hippocampus being highly enriched
with adenosine A1 receptors (Rivkees et al., 1995) receivesdopaminergic projection, which releases the dopamine that could
bind on the D1 receptors (Trantham-Davidson et al., 2004). In this
area, the immunohistochemistry identiﬁcation of DARPP-32 is
signiﬁcantly lower than other areas observed here (Ouimet et al.,
1984). Since our results demonstrated no change in DARPP-32
content in the hippocampus following treatment with caffeine or
MPH, we suggest that the long-lasting effect of caffeine on the
DARPP-32 content in the striatumand prefrontal cortexwas due its
action on the adenosine A2A receptors.
The several studies that investigated the effect of caffeine in
behavior point to molecular action. It is essential to associate
caffeinewith the other psychostimulant, since both substances can
modulate acutely or chronically the neural cells in the brain.
Caffeine is the most widely consumed psychoactive substance on
earth and is used at least weekly by nearly all adults, thus
investigations on its interaction with neurotransmission system,
such as the dopaminergic system, have been ongoing since several
years. However, little is known about its chronic use in lower doses
in children treated for psychiatric disorders. In the present work,
we investigated the sensitization expression following chronic
caffeine administration in adolescence to MPH in adulthood,
evaluating the behavior- and biochemistry alterations in rats. The
results showed important cross-sensitization effects induced by
caffeine to MPH with the participation of DARPP-32 protein in the
dopaminergic brain areas involved in the regulation of motor- and
action behaviors.
Acknowledgements
This research was supported by grants from UNESC and CNPq.
References
Acquas, E., Tanda, G., Di Chiara, G., 2002. Differential effects of caffeine on dopamine
and acetylcholine transmission in brain areas of drug-naive and caffeine-
pretreated rats. Neuropsychopharmacology 27, 182–193.
Aizenstein, M.L., Segal, D.S., Kuczenski, R., 1990. Repeated amphetamine and
fencamfamine: sensitization and reciprocal cross-sensitization. Neuropsycho-
pharmacology 3, 283–290.
Anderson, K.D., Reiner, A., 1991. Immunohistochemical localization of DARPP-32 in
striatal projection neurons and striatal interneurons: implications for the
localization of D1-like dopamine receptors on different types of striatal neu-
rons. Brain Res. 568 (1–2), 235–243.
Bastia, E., Xu, Y.H., Scibelli, A.C., Day, Y.J., Linden, J., Chen, J.F., Schwarzschild, M.A.,
2005. A crucial role for forebrain adenosine A(2A) receptors in amphetamine
sensitization. Neuropsychopharmacology 30, 891–900.
Bernstein, G.A., Carroll, M.E., Thuras, P.D., Cosgrove, K.P., Roth, M.E., 2002. Caffeine
dependence in teenagers. Drug Alcohol Depend. 66, 1–6.
Bibb, J.A., Chen, J., Taylor, J.R., Svenningsson, P., Nishi, A., Snyder, G.L., Yan, Z.,
Sagawa, Z.K., Ouimet, C.C., Nairn, A.C., Nestler, E.J., Greengard, P., 2001. Effects of
chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature
410, 376–380.
Borgkvist, A., Fisone, G., 2007. Psychoactive drugs and regulation of the cAMP/PKA/
DARPP-32 cascade in striatal medium spiny neurons. Neurosci. Biobehav. Rev.
31, 79–88.
Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of micro-
gram quantities of protein utilizing the principle of protein–dye binding. Anal.
Biochem. 72, 248–254.
da Silva, R.S., Bruno, A.N., Battastini, A.M., Sarkis, J.J., Lara, D.R., Bonan, C.D., 2003.
Acute caffeine treatment increases extracellular nucleotide hydrolysis from rat
striatal and hippocampal synaptosomes. Neurochem. Res. 28, 1249–1254.
da Silva, R.S., Hoffman, A., de Souza, D.O., Lara, D.R., Bonan, C.D., 2005. Maternal
caffeine intake impairs MK-801-induced hyperlocomotion in young rats. Eur. J.
Pharmacol. 509, 155–159.
Dall’Igna, O.P., Da Silva, A.L., Dietrich, M.O., Hoffmann, A., de Oliveira, R.V., Souza,
D.O., Lara, D.R., 2003. Chronic treatment with caffeine blunts the hyperloco-
motor but not cognitive effects of theN-methyl-D-aspartate receptor antagonist
MK-801 in mice. Psychopharmacology (Berl.) 166, 258–263.
El Yacoubi, M., Ledent, C., Menard, J.F., Parmentier, M., Costentin, J., Vaugeois, J.M.,
2000. The stimulant effects of caffeine on locomotor behaviour in mice are
mediated through its blockade of adenosine A(2A) receptors. Br. J. Pharmacol.
129, 1465–1473.
Fenu, S., Morelli, M., 1998. Motor stimulant effects of caffeine in 6-hydroxydopa-
mine-lesioned rats are dependent on previous stimulation of dopamine recep-
tors: a different role of D1 and D2 receptors. Eur. J. Neurosci. 10, 1878–1884.
C.R. Boeck et al. / Neurochemistry International 55 (2009) 318–322322Ferre, S., Ciruela, F., Canals, M., Marcellino, D., Burgueno, J., Casado, V., Hillion, J.,
Torvinen, M., Fanelli, F., Benedetti Pd, P., Goldberg, S.R., Bouvier, M., Fuxe, K.,
Agnati, L.F., Lluis, C., Franco, R., Woods, A., 2004. Adenosine A2A-dopamine D2
receptor–receptor heteromers. Targets for neuro-psychiatric disorders. Parkin-
sonism Relat. Disord. 10, 265–271.
Fink, J.S., Weaver, D.R., Rivkees, S.A., Peterfreund, R.A., Pollack, A.E., Adler, E.M.,
Reppert, S.M., 1992. Molecular cloning of the rat A2 adenosine receptor:
selective co-expression with D2 dopamine receptors in rat striatum. Brain
research. Mol. Brain Res. 14, 186–195.
Fisone, G., Borgkvist, A., Usiello, A., 2004. Caffeine as a psychomotor stimulant:
mechanism of action. Cell. Mol. Life Sci. (CMLS) 61, 857–872.
Franco, R., Lluis, C., Canela, E.I., Mallol, J., Agnati, L., Casado, V., Ciruela, F., Ferre, S.,
Fuxe, K., 2007. Receptor–receptor interactions involving adenosine A1 or
dopamine D1 receptors and accessory proteins. J. Neural Transm. 114, 93–104.
Fredholm, B.B., 1977. Activation of adenylate cyclase from rat striatum and tuber-
culum olfactorium by adenosine. Med. Biol. 55, 262–267.
Garrett, B.E., Holtzman, S.G., 1994. D1 and D2 dopamine receptor antagonists block
caffeine-induced stimulation of locomotor activity in rats. Pharmacol. Biochem.
Behav. 47, 89–94.
Horger, B.A.,Wellman, P.J.,Morien, A., Davies, B.T., Schenk, S., 1991. Caffeine exposure
sensitizes rats to the reinforcing effects of cocaine. Neuroreport 2, 53–56.
Jain, R., Holtzman, S.G., 2005. Caffeine induces differential cross tolerance to the
amphetamine-like discriminative stimulus effects of dopaminergic agonists.
Brain Res. Bull. 65, 415–421.
Karcz-Kubicha, M., Antoniou, K., Terasmaa, A., Quarta, D., Solinas, M., Justinova, Z.,
Pezzola, A., Reggio, R., Muller, C.E., Fuxe, K., Goldberg, S.R., Popoli, P., Ferre, S.,
2003. Involvement of adenosine A1 and A2A receptors in the motor effects of
caffeine after its acute and chronic administration. Neuropsychopharmacology
28, 1281–1291.
Lin, X.H., Hashimoto, T., Kitamura, N., Murakami, N., Shirakawa, O., Maeda, K., 2002.
Decreased calcineurin and increased phosphothreonine–DARPP-32 in the stria-
tumof rats behaviorally sensitized tomethamphetamine. Synapse 44, 181–187.
Lindskog, M., Svenningsson, P., Pozzi, L., Kim, Y., Fienberg, A.A., Bibb, J.A., Fredholm,
B.B., Nairn, A.C., Greengard, P., Fisone, G., 2002. Involvement of DARPP-32
phosphorylation in the stimulant action of caffeine. Nature 418, 774–778.
Oliveto, A.H., Hughes, J.R., Higgins, S.T., Bickel, W.K., Pepper, S.L., Shea, P.J., Fenwick,
J.W., 1992. Forced-choice versus free-choice procedures: caffeine self-admin-
istration in humans. Psychopharmacology (Berl.) 109, 85–91.
Ouimet, C.C., Miller, P.E., Hemmings Jr., H.C., Walaas, S.I., Greengard, P., 1984.
DARPP-32, a dopamine- and adenosine 30:50-monophosphate-regulated phos-
phoprotein enriched in dopamine-innervated brain regions. III. Immunocyto-
chemical localization. J. Neurosci. 4, 111–124.
Pollak, C.P., Bright, D., 2003. Caffeine consumption and weekly sleep patterns in US
seventh-, eighth-, and ninth-graders. Pediatrics 111, 42–46.
Rivkees, S.A., Price, S.L., Zhou, F.C., 1995. Immunohistochemical detection of A1
adenosine receptors in rat brain with emphasis on localization in the hippo-
campal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Res.
677, 193–203.Scheggi, S., Raone, A., De Montis, M.G., Tagliamonte, A., Gambarana, C., 2007.
Behavioral expression of cocaine sensitization in rats is accompanied by a
distinct pattern of modiﬁcations in the PKA/DARPP-32 signaling pathway. J.
Neurochem. 103, 1168–1183.
Schenk, S., Horger, B., Snow, S., 1990. Caffeine preexposure sensitizes rats to the
motor activating effects of cocaine. Behav. Pharmacol. 1, 447–451.
Simola, N., Cauli, O., Morelli, M., 2006a. Sensitization to caffeine and cross-sensi-
tization to amphetamine: inﬂuence of individual response to caffeine. Behav.
Brain Res. 172, 72–79.
Simola, N., Tronci, E., Pinna, A., Morelli, M., 2006b. Subchronic-intermittent caffeine
ampliﬁes the motor effects of amphetamine in rats. Amino Acids 31, 359–363.
Solinas, M., Ferre, S., You, Z.B., Karcz-Kubicha, M., Popoli, P., Goldberg, S.R., 2002.
Caffeine induces dopamine and glutamate release in the shell of the nucleus
accumbens. J. Neurosci. 22, 6321–6324.
Stoof, J.C., Kebabian, J.W., 1981. Opposing roles for D-1 and D-2 dopamine receptors
in efﬂux of cyclic AMP from rat neostriatum. Nature 294, 366–368.
Svenningsson, P., Lindskog, M., Ledent, C., Parmentier, M., Greengard, P., Fred-
holm, B.B., Fisone, G., 2000. Regulation of the phosphorylation of the dopa-
mine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine
D1, dopamine D2, and adenosine A2A receptors. Proc. Natl. Acad. Sci. U.S.A.
97, 1856–1860.
Torres-Reveron, A., Dow-Edwards, D.L., 2005. Repeated administration of methyl-
phenidate in young, adolescent, and mature rats affects the response to cocaine
later in adulthood. Psychopharmacology (Berl.) 181, 38–47.
Towbin, H., Staehelin, T., Gordon, J., 1979. Electrophoretic transfer of proteins from
polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. U.S.A. 76, 4350–4354.
Trantham-Davidson, H., Neely, L.C., Lavin, A., Seamans, J.K., 2004. Mechanisms
underlying differential D1 versus D2 dopamine receptor regulation of inhibition
in prefrontal cortex. J. Neurosci. 24, 10652–10659.
Tsai, S.J., 2005. Adenosine A2a receptor/dopamine D2 receptor hetero-oligomeriza-
tion: a hypothesis that may explain behavioral sensitization to psychostimu-
lants and schizophrenia. Med. Hypotheses 64, 197–200.
Valvassori, S.S., Frey, B.N., Martins, M.R., Reus, G.Z., Schimidtz, F., Inacio, C.G.,
Kapczinski, F., Quevedo, J., 2007. Sensitization and cross-sensitization after
chronic treatment with methylphenidate in adolescent Wistar rats. Behav.
Pharmacol. 18, 205–212.
Vianna, M.R., Izquierdo, L.A., Barros, D.M., de Souza, M.M., Rodrigues, C., Sant’Anna,
M.K., Medina, J.H., Izquierdo, I., 2001. Pharmacological differences between
memory consolidation of habituation to an open ﬁeld and inhibitory avoidance
learning. Braz. J. Med. Biol. Res. 34, 233–240.
Walaas, S.I., Aswad, D.W., Greengard, P., 1983. A dopamine- and cyclic AMP-
regulated phosphoprotein enriched in dopamine-innervated brain regions.
Nature 301, 69–71.
Yabuuchi, K., Kuroiwa, M., Shuto, T., Sotogaku, N., Snyder, G.L., Higashi, H., Tanaka,
M., Greengard, P., Nishi, A., 2006. Role of adenosine A1 receptors in the
modulation of dopamine D1 and adenosine A2A receptor signaling in the
neostriatum. Neuroscience 141, 19–25.
